• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody

EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody [clone EMI1/1176] (V2527)

  Catalog No Formulation Size Price (USD)  
Image V2527-100UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 100 ug 559
Image
V2527-20UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 20 ug 259
Image
V2527SAF-100UG 1 mg/ml in 1X PBS; BSA free, sodium azide free 100 ug 559
Image
V2527IHC-7ML Prediluted in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide; *For IHC use only* 7 ml 559
Microvalidated
Bulk quote request
EMI1 Antibody Ovarian Carcinoma IHC. Immunohistochemistry analysis of formalin-fixed, paraffin-embedded human ovarian carcinoma tissue stained with EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody clone EMI1/1176 demonstrates prominent nuclear HRP-DAB brown staining throughout malignant epithelial cell populations, consistent with the role of Early mitotic inhibitor 1 / FBXO5 in proliferative signaling, APC/C-associated checkpoint regulation, and mitotic progression control. The predominantly nuclear staining pattern aligns with the function of EMI1 as a cell cycle regulatory protein involved in maintenance of orderly cell cycle progression and genomic stability.
EMI1 Antibody Multi-Cell Line WB. Western blot analysis of 1) HeLa, 2) HepG2, 3) human 293, and 4) K562 cell lysates using EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody demonstrates distinct bands at approximately 45-50 kDa, consistent with the predicted molecular weights of Early mitotic inhibitor 1 / FBXO5 isoforms 1 and 2. The observed expression pattern aligns with the role of EMI1 as a regulator of APC/C-associated checkpoint signaling, mitotic progression, and proliferative cell cycle control.
EMI1 Antibody Microarray Specificity Validation. Analysis of a HuProt(TM) human protein microarray containing more than 19,000 full-length human proteins using clone EMI1/1176 demonstrates highly selective binding to Early mitotic inhibitor 1 / FBXO5 with minimal off-target reactivity detected across the tested human proteome. The strong enrichment of EMI1 signal relative to lower-ranking proteins supports the specificity of this monoclonal antibody for studies involving mitotic checkpoint regulation, APC/C-associated signaling, and proliferative cell cycle control.
Z- and S-score interpretation: The Z-score represents the signal intensity generated when an antibody, together with a fluorescently labeled secondary antibody, binds to a specific protein target on the HuProt(TM) array. Z-scores are expressed as standard deviations above the mean signal intensity of all proteins present on the array. Proteins are ranked according to descending Z-score values, and the S-score represents the difference in Z-score between sequentially ranked proteins. The S-score therefore reflects the relative specificity of an antibody for its intended target compared to other proteins represented on the array.
Availability 1-3 business days
Species Reactivity Human
Format Purified
Host Mouse
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG2a, kappa
Clone Name EMI1/1176
Purity Protein G affinity chromatography
UniProt Q9UKT4
Localization Nuclear
Applications Western Blot : 1-2ug/ml for 60 min at RT
Immunohistochemistry (FFPE) : 1-2ug/ml for 30 min at RT
Limitations This EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

F-box only protein 5 (FBXO5), also known as Early mitotic inhibitor 1 (EMI1), is a cell cycle regulatory protein involved in control of S phase progression, mitotic entry, and APC/C-associated checkpoint signaling. The EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody clone EMI1/1176 is designed for highly selective detection of EMI1 expression in studies involving cell cycle progression, mitotic regulation, and replication-associated signaling pathways.

EMI1 is encoded by the FBXO5 gene on chromosome 6q25 and functions primarily within the nucleus and cytoplasmic cell cycle regulatory compartments. The protein acts as an inhibitor of the anaphase-promoting complex/cyclosome (APC/C), thereby preventing premature degradation of cyclins and other proteins required for orderly cell cycle progression. Through this regulatory role, EMI1 contributes to maintenance of genomic stability and proper timing of mitotic transitions.

Expression of EMI1 is tightly coordinated with proliferative activity and is frequently elevated during actively cycling cellular states. The protein accumulates during S and G2 phases and is subsequently degraded during mitosis through SCF-betaTrCP-mediated ubiquitination pathways. Dysregulation of EMI1 expression has been associated with aberrant proliferation, chromosomal instability, replication stress responses, and oncogenic transformation across multiple tumor types.

EMI1 also participates in broader networks governing DNA replication licensing and checkpoint-associated signaling. By modulating APC/C activity, EMI1 helps preserve the stability of proteins required for DNA synthesis and mitotic fidelity. Loss of proper EMI1 regulation may contribute to rereplication events, mitotic defects, and altered cellular sensitivity to genotoxic stress. These biologic functions have generated continued interest in EMI1 across cancer biology, cell cycle research, and therapeutic response studies.

The clone EMI1/1176 monoclonal antibody is further differentiated by protein microarray specificity validation performed against a HuProt(TM) array containing more than 19,000 full-length human proteins. This large-scale specificity screening approach helps evaluate potential cross-reactivity across the human proteome and is particularly valuable for cell cycle-associated proteins that share conserved regulatory domains and overlapping molecular interactions. The resulting specificity profile supports use of this EMI1 antibody in studies where selective target recognition and reduced off-target binding are important experimental considerations.

Immunohistochemical and western blot analyses using EMI1 antibodies commonly demonstrate expression patterns associated with proliferative cellular compartments and actively cycling tumor populations. EMI1 continues to serve as an important marker within studies involving mitotic checkpoint regulation, APC/C signaling, replication stress biology, and tumor-associated proliferative pathways.

Additional antibodies involved in mitotic regulation, DNA replication control, and proliferative checkpoint signaling can be explored within our Signal Transduction Antibodies collection.

Application Notes

Optimal dilution of the EMI1 Antibody / Cell Cycle Checkpoint Regulator Antibody should be determined by the researcher.

1. Staining of formalin-fixed tissues requires boiling tissue sections in pH 9 10mM Tris with 1mM EDTA for 10-20 min followed by cooling at RT for 20 minutes
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Immunogen

A recombinant fragment (203 amino acid residues between aa 1-250) from the human protein was used as the immunogen for the EMI1 antibody.

Storage

Store the EMI1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Alternate Names

EMI1 antibody, FBXO5 antibody, Early mitotic inhibitor 1 antibody, Cell cycle checkpoint regulator antibody, APC/C regulator antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.